AI assistant
Merck & Co., Inc. — Director's Dealing 2019
Dec 16, 2019
284_dirs_2019-12-16_33f8f9ec-c289-4174-86ed-7e7208a1ea6a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2019-05-03
Reporting Person: Fleming Michael (SVP Chief Ethics & Com Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-03 | Restricted Stock Unit | $ | A | 4625 | Acquired | 2022-05-03 | Common Stock (4625) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2: The original Form 4, filed on May 7, 2019, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the number of restricted stock units granted on May 3, 2019. As a result of this administrative error, the number of restricted stock units granted to the reporting person following the corrected transaction reflects an increase by 3,125 shares in the number of restricted stock units reported.
F3: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.